University Hospital, Clermont-Ferrand
Clermont-Ferrand, Auvergne, 63003, France
NCT Number: NCT06734390
Surgical outcomes of bladder neck surgery in children with neurogenic bladder. Consequences on bladder voiding.
Looking for future studies?
Notify Me0 year–17 year
All sexes
Observational
Clermont-Ferrand, Auvergne, 63003, France
Surgical outcomes of bladder neck surgery in children with neurogenic bladder:
Quality of voiding: spontaneous, need for catheterization, or incontinence. Other surgical complications.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bladder Neck Surgery regroups many surgical procedures to cure urinary incontinence.
Time frame: Before surgery
Abdominal ultrasound, cysto-urethrogram and uroflowmetry help diagnose delayed or incomplete opening of the bladder neck.
Time frame: Through study completion, an average of 2 years
Reporting if the patients are dry or need catheterizations or protections
Time frame: From admission to discharge home, up to 20 days
Length of stay
Time frame: Through study completion, an average of 2 years
bleeding, bowel obstruction, surgical hernia, urinary stone, urinary infection
Time frame: Through study completion, an average of 2 years
The time length between the surgery date and the postoperative consultation date.
Follow-up represents the time between the surgery and postoperative consultation dates in days, months, or years.
University Hospital, Clermont-Ferrand
Other
Management of Patients Under 18 Years of Age Who Have Had Bladder Neck Procedures
Acronym: CERPED
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02616081
Central Nervous System Diseases, Female Urogenital Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT02978638
Central Nervous System Diseases, Female Urogenital Diseases
Palo Alto, California, United States
View Trial DetailsNCT06206512
Cardiovascular Diseases, Female Urogenital Diseases
Dallas, Texas, United States
View Trial DetailsNCT06470620
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Haifa, Haifa District, Israel
View Trial Details